Endex Co., Ltd.
Cave Creek, Arizona, March 27, 2024 (Globe Newswire) — via NewMediaWire — Endex Co., Ltd. (OTC: EDXC), a pioneer in plant-based wellness and the parent company of the innovative HYLA brand, today announced an expansionary plan driven by recent legislative changes in Europe and strategic expansion into new international markets. announced a strategic strategy to take advantage of this opportunity. This initiative aims to position EDXC and its HYLA division at the forefront of the rapidly evolving cannabis and plant-based wellness landscape.
Germany’s landmark legalization of cannabis, covered by Investor’s Business Daily, heralds a transformative era for European markets and presents unparalleled opportunities for forward-thinking companies like Endexx Corporation. There is. Endexx is strategically positioned to leverage its expertise in plant-based active compounds, including cutting-edge cannabis services, formulations and delivery technologies, to meet rapidly growing demand across Europe.
Claude Zydnow, a prominent member of the Board of Directors of Endexx Corporation, expressed his enthusiasm about the legal changes in Europe, and in particular Germany, stating that “Legal changes in Europe, and in particular Germany, are a significant step forward for our innovative plant-based and e-cigarette product line. We are taking advantage of the global shift towards cannabis acceptance and the surge in demand for wellness products to introduce and reach new markets with our unique formulations and superior quality products. We would like to expand. ”
Endexx’s HYLA division has already made great strides, uniquely offering zero-natural ingredients and zero-nicotine vaping products that are gaining significant traction in diverse international markets, including the Middle East and Europe. With the recent distribution agreement with UAE’s Sahara Trading and strategic partnership with Italy’s XVI Ventures, HYLA is poised for exponential growth and increased market penetration.
Additionally, Endexx Corporation has launched TPD registration in Europe, further strengthening its market presence and paving the way for expanded distribution across the continent.
Endexx Corporation is committed to sustainability, wellness and innovation and invests in research and development, strategic marketing and global expansion efforts to take advantage of evolving market dynamics and the regulatory landscape. The company’s proactive stance in embracing regulatory changes and exploring new market opportunities is poised to drive significant growth and create significant value for shareholders in the coming years.
About Endex Co., Ltd.
Endexx Corporation develops and markets all-natural, plant-based wellness and trending skin care products. Its products range from balms, creams, lotions, butters, masks, scrubs and oils, all with the common goal of healthy skin and well-being. The science behind these products includes 10 years of clinical and laboratory research to provide functional formulations with ingredients for optimal absorption and skin health support. Masu. www.endex.com
About Hyla
Hyla currently sells proprietary non-nicotine, guarana, L-dopa-based e-cigarette products in a variety of flavors. The Hyla device is the first non-nicotine vape product manufactured this way in the United States, delivering an unprecedented 4,500 puffs per device. Hyla is currently distributed in 10 countries and has distribution agreements in place with nine more. www.tryhyla.com
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
This presentation may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding financial results and plans for future development activities. Forward-looking statements include all statements that are not statements of historical fact regarding the intentions, beliefs or current expectations of the Company, its directors or officers. Investors are cautioned that such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s control. Actual results may differ materially from those anticipated in the forward-looking statements. Factors that could cause actual results to differ materially from those expressed in the forward-looking statements include, but are not limited to, factors such as growth, competition, global economic conditions, and our ability to continue to manage and manage competition; It involves risks and uncertainties related to general finance. and other factors described more fully in the Company’s periodic filings with the Securities and Exchange Commission. We undertake no obligation to update any forward-looking statements.
There are no offers or solicitations. This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities. You may not sell securities. the laws of such jurisdiction. No offering of securities shall be made except by means of a prospectus that meets the requirements of Section 10 of the Securities Act of 1933, as amended, and, if applicable, the securities laws of other relevant jurisdictions. will do.
For more information, please contact us below.
Endex Co., Ltd.
IR@Endexx.com
attachment
